Report Detail

Pharma & Healthcare Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3669035
  • |
  • 19 August, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 NK Cell Therapies
      • 1.4.3 NK Cell Directed Antibodies
    • 1.5 Market by Application
      • 1.5.1 Global Natural Killer Cells Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Research Centers & Institutes
      • 1.5.3 Hospitals
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Natural Killer Cells Therapeutics Market Size
    • 2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
      • 2.2.1 Natural Killer Cells Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Natural Killer Cells Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Natural Killer Cells Therapeutics Market Size by by Players
      • 3.1.1 Global Natural Killer Cells Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Natural Killer Cells Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Natural Killer Cells Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Natural Killer Cells Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Natural Killer Cells Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Natural Killer Cells Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 5.2 Natural Killer Cells Therapeutics Key Players in North America
    • 5.3 North America Natural Killer Cells Therapeutics Market Size by Type
    • 5.4 North America Natural Killer Cells Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 6.2 Natural Killer Cells Therapeutics Key Players in Europe
    • 6.3 Europe Natural Killer Cells Therapeutics Market Size by Type
    • 6.4 Europe Natural Killer Cells Therapeutics Market Size by Application

    7 China

    • 7.1 China Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 7.2 Natural Killer Cells Therapeutics Key Players in China
    • 7.3 China Natural Killer Cells Therapeutics Market Size by Type
    • 7.4 China Natural Killer Cells Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 8.2 Natural Killer Cells Therapeutics Key Players in Japan
    • 8.3 Japan Natural Killer Cells Therapeutics Market Size by Type
    • 8.4 Japan Natural Killer Cells Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 9.2 Natural Killer Cells Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Natural Killer Cells Therapeutics Market Size by Type
    • 9.4 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application

    10 India

    • 10.1 India Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 10.2 Natural Killer Cells Therapeutics Key Players in India
    • 10.3 India Natural Killer Cells Therapeutics Market Size by Type
    • 10.4 India Natural Killer Cells Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Natural Killer Cells Therapeutics Market Size (2014-2019)
    • 11.2 Natural Killer Cells Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Natural Killer Cells Therapeutics Market Size by Type
    • 11.4 Central & South America Natural Killer Cells Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Affimed
      • 12.1.1 Affimed Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Natural Killer Cells Therapeutics Introduction
      • 12.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2014-2019))
      • 12.1.5 Affimed Recent Development
    • 12.2 Celgene Corporation
      • 12.2.1 Celgene Corporation Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Natural Killer Cells Therapeutics Introduction
      • 12.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.2.5 Celgene Corporation Recent Development
    • 12.3 Fate Therapeutics
      • 12.3.1 Fate Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Natural Killer Cells Therapeutics Introduction
      • 12.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.3.5 Fate Therapeutics Recent Development
    • 12.4 Fortress Biotech
      • 12.4.1 Fortress Biotech Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Natural Killer Cells Therapeutics Introduction
      • 12.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.4.5 Fortress Biotech Recent Development
    • 12.5 Glycostem Therapeutics
      • 12.5.1 Glycostem Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Natural Killer Cells Therapeutics Introduction
      • 12.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.5.5 Glycostem Therapeutics Recent Development
    • 12.6 Innate Pharma
      • 12.6.1 Innate Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Natural Killer Cells Therapeutics Introduction
      • 12.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.6.5 Innate Pharma Recent Development
    • 12.7 Nantkwest
      • 12.7.1 Nantkwest Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Natural Killer Cells Therapeutics Introduction
      • 12.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.7.5 Nantkwest Recent Development
    • 12.8 Nkarta Therapeutics
      • 12.8.1 Nkarta Therapeutics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Natural Killer Cells Therapeutics Introduction
      • 12.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.8.5 Nkarta Therapeutics Recent Development
    • 12.9 NKT Therapeutics
      • 12.9.1 NKT Therapeutics Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Natural Killer Cells Therapeutics Introduction
      • 12.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.9.5 NKT Therapeutics Recent Development
    • 12.10 Ziopharm Oncology
      • 12.10.1 Ziopharm Oncology Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Natural Killer Cells Therapeutics Introduction
      • 12.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2014-2019)
      • 12.10.5 Ziopharm Oncology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Natural Killer Cells Therapeutics are type of immune cell that has granules (small particles) with enzymes that can kill tumor cells or cells infected with a virus. A natural killer cell is a type of white blood cell. Also called NK cell and NK-LGL.
      In 2018, the global Natural Killer Cells Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Affimed
      Celgene Corporation
      Fate Therapeutics
      Fortress Biotech
      Glycostem Therapeutics
      Innate Pharma
      Nantkwest
      Nkarta Therapeutics
      NKT Therapeutics
      Ziopharm Oncology

      Market segment by Type, the product can be split into
      NK Cell Therapies
      NK Cell Directed Antibodies

      Market segment by Application, split into
      Research Centers & Institutes
      Hospitals
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Natural Killer Cells Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Natural Killer Cells Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Natural Killer Cells Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Natural Killer Cells Therapeutics. Industry analysis & Market Report on Natural Killer Cells Therapeutics is a syndicated market report, published as Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Natural Killer Cells Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,007.61
      4,511.41
      6,015.21
      3,495.74
      5,243.61
      6,991.48
      423,419.10
      635,128.65
      846,838.20
      276,644.16
      414,966.24
      553,288.32
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report